Ayman R Fath
Overview
Explore the profile of Ayman R Fath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fath A, Aglan A, Maron M, Phillips J, Maron B, Rowin E
Int J Cardiol
. 2025 Feb;
426:133082.
PMID: 39983877
Background: Obesity is highly prevalent in patients with hypertrophic cardiomyopathy (HCM) and associated with a more severe phenotype and worse outcomes. Glucagon-like peptide-1 (GLP-1) receptor agonists have recently been shown...
2.
Naveed M, Neppala S, Chigurupati H, Rehan M, Ali A, Naveed H, et al.
Am Heart J Plus
. 2025 Jan;
49:100491.
PMID: 39760108
Background: Stroke associated with atrial fibrillation (AF) is a significant cause of mortality. This study analyzed demographic trends and disparities in mortality rates due to stroke in AF patients aged...
3.
4.
Fath A, Aglan A, Altaee O, Fichardt H, Mansoor H, Almomani A, et al.
JACC Clin Electrophysiol
. 2024 Oct;
10(12):2701-2710.
PMID: 39365213
Background: The efficacy of direct oral anticoagulants (DOACs) in preventing ischemic and thromboembolic events may be suboptimal in atrial fibrillation (AF) patients with rheumatic mitral stenosis. However, their safety and...
5.
Fath A, Elgendy I
Ann Intern Med
. 2024 Sep;
177(9):JC105.
PMID: 39222516
Alshahrani NS, Hartley A, Howard J, et al. J Am Coll Cardiol. 2024;83:2250-2259. 38588928.
6.
Aglan A, Fath A, Eldaly A, Anderson A, Phillips J, Maron B, et al.
JACC Adv
. 2024 Jun;
3(3):100843.
PMID: 38938829
No abstract available.
7.
Aglan A, Fath A, Maron B, Maron M, Prasad A, Almomani A, et al.
Heart Rhythm
. 2024 May;
21(9):1677-1683.
PMID: 38797308
Background: Percutaneous left atrial appendage closure (LAAC) is an effective alternative strategy for stroke prevention in patients with atrial fibrillation (AF) at high risk for bleeding with anticoagulation (AC). Efficacy...
8.
Fath A, Aglan M, Aglan A, Chilton R, Trakhtenbroit A, Al-Shammary O, et al.
Am J Cardiol
. 2024 May;
222:175-182.
PMID: 38692401
Anthracyclines are pivotal in cancer treatment, yet their clinical utility is hindered by the risk of cardiotoxicity. Preclinical studies highlight the effectiveness of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in mitigating anthracycline-induced...
9.
Aglan A, Maraey A, Fath A, Elsharnoby H, Abdelmottaleb W, Elzanaty A, et al.
JACC Cardiovasc Interv
. 2024 Feb;
17(4):520-530.
PMID: 38418055
Background: Clinical trials have demonstrated the efficacy and safety of mitral transcatheter edge-to-edge repair (M-TEER) for selected patients with severe mitral regurgitation. However, the generalizability of trial results to real-world...
10.
Fath A, Aglan A, Khurana A, Abuasbeh J, Eldaly A, Mantha Y, et al.
Am J Cardiol
. 2023 Aug;
205:363-368.
PMID: 37647820
The use of transcatheter aortic valve replacement (TAVR) in the United States has been increasing but with variability. We used a 100% sample of Medicare beneficiaries (MBs), from the Centers...